Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

Steffen Durinck, Somasekar Seshagiri(Sarepta Therapeutics (United States)), Subhra Chaudhuri, Karen Toy, Frédéric J. de Sauvage(Gene Therapy Laboratory), Sadia Saleem(The University of Texas Southwestern Medical Center), Eric Stawiski(Caribou Biosciences (United States)), Thomas D. Wu, Corissa J Harris, Haley Hill(The University of Texas Southwestern Medical Center), Iván Pedrosa(The University of Texas Southwestern Medical Center), Weiru Wang(Guangzhou Institute of Geochemistry), Celina Sanchez Rivers, Yair Lotan(Southwestern Medical Center), James Brugarolas(The University of Texas Southwestern Medical Center), Samuel Peña‐Llopis(Essen University Hospital), Lisa N. Kinch(The University of Texas Southwestern Medical Center), Vanina Toffessi-Tcheuyap(The University of Texas Southwestern Medical Center), Kanika Bajaj Pahuja, Peter M. Haverty, Bijay S. Jaiswal(AbbVie (United States)), Andrea Pavía-Jiménez(The University of Texas Southwestern Medical Center), Payal Kapur(Southwestern Medical Center), Vasantharajan Janakiraman, Zora Modrušan(Unknown), Julian Gehring, Ying‐Jiun Chen, Arthur I. Sagalowsky(The University of Texas Southwestern Medical Center), Marlena Jackson, Bernard Chow, Grégoire Pau, Sherry Heldens, Joseph Guillory, Thong Tien Nguyen, Vitaly Margulis(Southwestern Medical Center), Na Zhang(Shanghai Institute of Organic Chemistry), Nick V. Grishin(Smithsonian Institution), Jeremy Stinson, Eboni Holloman(The University of Texas Southwestern Medical Center), Jens Reeder, Connie Ha
Nature Genetics
November 17, 2014
Cited by 359


Related Papers